Sydney Lupkin
Stories
-
Novo Nordisk CEO is grilled by a Senators about high cost of Ozempic
Sen. Bernie Sanders questions Novo Nordisk CEO Lars Jorgensen in a hearing on Capitol Hill about the high prices Americans pay for Ozempic and Wegovy compared with people in other countries.
-
FTC sues insulin middlemen, saying they pocket billions while patients face high costs
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially inflated the cost of insulin.
-
The FTC has filed a lawsuit over the artificially inflation of the price of insulin
The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.
-
Drugmakers say obesity medicine shortages are easing, but patients struggle to fill prescriptions
The drug companies behind blockbuster weight loss and diabetes treatments have signaled that supply problems could soon be over, but many patients still have trouble getting the medicines.
-
Drug makers including Pfizer are starting to sell drugs directly to consumers
In a move that might allow them to sell drugs directly to patients, some drugmakers are getting into the telehealth business.
-
Drug makers including Pfizer are starting to sell drugs directly to consumers
Some drugmakers are getting into the telehealth business in a move that might allow them to sell drugs directly to patients.
-
Medicare negotiated lower prices on several drugs. What does that mean for patients?
For six of the 10 drugs that Medicare negotiated to lower prices, the net prices aren't any better than the ones insurers already get. But there may be a change in patients' choices of medicines.
-
Biden and Harris celebrate 'landmark' move to lower prescription drug prices
President Biden and Vice President Harris are using their first recent joint appearance to talk about prescription drug prices.
-
Medicare negotiated drug prices for the first time. Here’s what it got
The White House announced new Medicare drug prices for 10 medicines popular with beneficiaries. It's the first time the federal program has negotiated lower prices with the pharmaceutical industry.
-
The Biden administration is wrapping up negotiations to lower prescription drug prices
The first price negotiations between Medicare and drug companies has been underway since February. What do we know about how it's going?
